Pheton Holdings Ltd, a healthcare solutions provider, develops and commercializes treatment software and devices used for brachytherapy. The companys proprietary treatment planning system is a radiation therapy used in treating cancer patients by placing radioactive sources inside the patient that kill cancer cells and shrink tumors. Its proprietary treatment planning system is FTTPS, a treatment planning system for treating various malignant tumors, which could determine the target volume, prescription dose, and dose limitation to protect organs at risks and produce dose distribution plan for brachytherapy for cancer patients. The company was founded in 1998 and is based in Beijing, China. Pheton Holdings Ltd is a subsidiary of ZJW (BVI) LTD. The company headquarter is located in China. The company was established in the 1998.

TickerPTHL
Long NamePheton Holdings Ltd Class A Ordinary Shares
Short NamePheton Holdings Ltd Class A